Skip to main content
SpringerLink
Log in

Pulmonary Alterations in Chronic Liver Failure

  • Chapter
  • First Online:
Chronic Liver Failure

Part of the book series: Clinical Gastroenterology ((CG))

  • 1392 Accesses

Abstract

Chronic liver failure can have profound effects on the lungs. Hepatic dysfunction affects the process of breathing (when awake or during sleep), impairs lung mechanics, and may cause dramatic changes in pulmonary circulation. These pulmonary alterations commonly result in symptoms of fatigue (possibly related to sleep-related breathing abnormalities) and dyspnea which can significantly affect the quality of life in addition to direct consequences of chronic liver failure.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Moller S, Krag A, Henriksen JH, Bendtsen F. Pathophysiological aspects of pulmonary complications of cirrhosis. Scand J Gastrol 2007; 42: 419–27.

    Article  Google Scholar 

  2. Anguiera CE, Kadakia SC. Effects of large-volume paracentesis on pulmonary function in patients with tense ascites. Hepatology 1994; 20: 825–8.

    Article  Google Scholar 

  3. Crespo J, Cifrian J, Pinto JA, et al. Sleep apnea obstructive syndrome: a new complication previously undescribed in cirrhotic patients with ascites. Am J Gastroenterol 2003; 98: 2815–6.

    Article  PubMed  Google Scholar 

  4. Akhtar AJ, Alamy ME, Yoshikawa TT. Extrahepatic conditions and hepatic encephalopathy in elderly patients. Am J Med Sci 2002; 324: 1–4.

    Article  PubMed  Google Scholar 

  5. Cordoba J, Cabrera J, Lataif L, et al. High prevalence of sleep disturbance in cirrhosis. Hepatology 1998; 27: 339–45.

    Article  CAS  PubMed  Google Scholar 

  6. Lustik SJ, Chibber AK, Kolan JW, et al. Hyperventilation of cirrhosis: progesterone and estradiol effects. Hepatology 1997; 25: 55–8.

    Article  CAS  PubMed  Google Scholar 

  7. Atkeson A, Yeh SY, Malhotra A, Jelic S. Endothelial function on obstructive sleep apnea. Prog Cardiovasc Dis 2009; 51: 351–62.

    Article  CAS  PubMed  Google Scholar 

  8. Okcay A, Wiesner RH, Krowka MJ, et al. Prevalence and clinical predictors of abnormal overnight oximetry in patients awaiting liver transplantation. Hepatology 2009; 50 (Suppl): A588 (abstract).

    Google Scholar 

  9. Vuppalanchi R, Naga Chalasani N. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: selected practical issues in their evaluation and management. Hepatology 2009; 49: 306–17.

    Article  PubMed  Google Scholar 

  10. Newton JL, Gibson J, Tomlinnson M, et al. Fatigue in primary biliary cirrhosis is associated with excessive daytime somnolence. Hepatology 2006; 44: 91–8.

    Article  PubMed  Google Scholar 

  11. Singh H, Pollock R, Uhanova J, Kryger M, Hawkins K, Minuk GY. Symptoms of obstructive sleep apnea in patients with nonalcoholic fatty liver disease. Dig Dis Sci 2005; 50: 2338–43.

    Article  PubMed  Google Scholar 

  12. Newton JL, Jones DE, Henderson E, Kane L, Wilton K, Burt AD, et al. Fatigue in non-alcoholic fatty liver disease (NAFLD) is significant and associates with inactivity and excessive daytime sleepiness but not with liver disease severity or insulin resistance. Gut 2008; 57: 807–13.

    Article  CAS  PubMed  Google Scholar 

  13. Kallwitz ER, Herdegen J, Madura J, et al. Liver enzymes and histology in obese patients with obstructive sleep apnea. J Clin Gastroenterology 2007; 41: 918–21.

    Article  CAS  Google Scholar 

  14. Tanne F, Gagnadoux F, Chazouilleres O, et al. Chronic liver injury during obstructive sleep apnea. Hepatology 2005; 41: 1290–5.

    Article  PubMed  Google Scholar 

  15. Degano B, Mittaine M, Guenard H, et al. Nitric oxide and carbon monoxide lung transfer in patients with advanced liver cirrhosis. J Appl Phys 2009; 107: 139–43.

    Article  CAS  Google Scholar 

  16. Kinasewitz GT, Kaddissi JI. Hepatic hydrothorax. Curr Opin Pulm Med 2003; 9: 261–5.

    Article  PubMed  Google Scholar 

  17. Xiol X, Tremosa G, Castellote J, et al. Liver transplantation in patients with hepatic hydrothorax. Transpl Int 2005; 18: 672–5.

    Article  PubMed  Google Scholar 

  18. Liu LU, Haddadin HA, Bodian CA, et al. Outcome analysis of cirrhotic patients undergoing chest tube placement. Chest 2004; 126: 142–8.

    Article  PubMed  Google Scholar 

  19. Krowka MJ, Mandell MS, Ramsay MAE, et al. Hepatopulmonary syndrome and portopulmonary hypertension: a report of the multicenter liver transplant database. Liver Transpl 2004; 10: 174–82.

    Article  PubMed  Google Scholar 

  20. Rodriguez-Roisin R, Krowka MJ. Hepatopulmonary syndrome: a liver-induced lung vascular disorder. N Engl J Med 2008; 358: 2378–87.

    Article  CAS  PubMed  Google Scholar 

  21. Zhang J, Luo B, Tang L, et al. Pulmonary angiogenesis in a rat model of hepatopulmonary syndrome. Gastroenterology 2009; 136: 1070–80.

    Article  CAS  PubMed  Google Scholar 

  22. Luo B, Lui L, Tang L, et al. Increase pulmonary vascular endothelin B receptor expression and responsiveness to endothelin-1 in cirrhotic and portal hypertensive rats: a potential mechanism for experimental hepatopulmonary syndrome. J Hepatol 2003; 38: 556–63.

    Article  CAS  PubMed  Google Scholar 

  23. Palma DT, Philips GM, Arguedas MR, et al. Oxygen desaturation during sleep in hepatopulmonary syndrome. Hepatology 2008; 47: 1257–63.

    Article  PubMed  Google Scholar 

  24. Gomez FP, Barbera JA, Roca J, et al. Effects of nebulized N(G)arginine methyl ester in patients with hepatopulmonary syndrome. Hepatology 2006; 43: 1084–91.

    Article  CAS  PubMed  Google Scholar 

  25. Schenk P, Schoniger-Hekele M, Fuhrman V, et al. Prognostic significance of the hepatopulmonary syndrome in patients with cirrhosis. Gastroenterology 2003; 125: 1042–52.

    Article  PubMed  Google Scholar 

  26. Swanson KL, Wiesner RH, Krowka MJ. Natural history of hepatopulmonary syndrome: impact of liver transplantation. Hepatology 2005; 1122–9.

    Google Scholar 

  27. Fallon MB, Mulligan DC, Gish RG, Krowka MJ. MELD exception for hepatopulmonary syndrome. Liver Transpl 2006; 12 (Suppl): S105–7.

    Article  PubMed  Google Scholar 

  28. Taille C, Cadranel J, Bellocq A, et al. Liver transplantation for hepatopulmonary syndrome: a ten-year experience in Paris, France. Transplantation 2003; 75: 1482–9.

    Article  PubMed  Google Scholar 

  29. Porres-Aguilar M, Zuckerman MJ, Figuerosa-Casas JB, Krowka MJ. Portopulmonary hypertension: state of the art. Ann Hepatol 2008; 7: 321–30.

    PubMed  Google Scholar 

  30. Le Pavec J, Souza R, Herve P, et al. Portopulmonary hypertension: survival and prognostic factors. Am J Respir Crit Care Med 2008; 178; 637–43.

    Article  PubMed  Google Scholar 

  31. Kawut SM, Krowka MJ, Trotter F, et al. Clinical risk factors for portopulmonary hypertension. Hepatology 2008; 48: 196–203.

    Article  PubMed  Google Scholar 

  32. Roberts KE, Fallon MB, Krowka MJ, et al. Genetic risk factors for portopulmonary hypertension in advanced liver disease. Am J Respir Crit Care Med 2009; 179: 835–42.

    Article  PubMed  Google Scholar 

  33. Krowka MJ, Swanson KL, Frantz RP, et al. Portopulmonary hypertension: results from a 10-year screening algorithm. Hepatology 2006; 44: 1502–10.

    Article  PubMed  Google Scholar 

  34. Swanson KL, Krowka MJ, Wiesner RH, et al. Survival in portopulmonary hypertension: Mayo Clinic experience categorized by treatment groups. Am J Transpl 2008; 8: 2445–53.

    Article  CAS  Google Scholar 

  35. Simonneau G, Robbins IM, Beghetti M, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Card 2009; 54 (Suppl): S44–55.

    Google Scholar 

  36. Hoeper MM, Seyfarth HJ, Hoeffken G, et al. Experience with inhaled iloprost and bosentan in portopulmonary hypertension. Eur Respir J 2007; 30: 1096–102.

    Article  CAS  PubMed  Google Scholar 

  37. Sussman N, Kaza V, Barshes N, et al. Successful liver transplantation following medical management of portopulmonary hypertension: a single center series. Am J Transpl 2006; 6: 2177–82.

    Article  CAS  Google Scholar 

  38. Fix OK, Bass NM, DeMarco T, Merriman RB. Long-term follow-up of portopulmonary hypertension: effect of treatment with epoprostenol. Liver Transpl 2007; 13: 875–85.

    Article  PubMed  Google Scholar 

  39. Ashfaq M, Chinnakoatla S, Rogers L, et al. The treatment impact of portopulmonary hypertension on survival after liver transplantation. Am J Transpl 2007; 7: 1258–64.

    Article  CAS  Google Scholar 

  40. Hemmes AR, Robbins IM. Sildenafil monotherapy in portopulmonary hypertension can facilitate liver transplantation. Liver Transpl 2009; 15: 15–9.

    Article  Google Scholar 

  41. Gough MS, White RJ. Sildenafil is associated with improved hemodynamics in liver transplantation candidates with pulmonary hypertension. Liver Transpl 2009; 15: 30–8.

    Article  PubMed  Google Scholar 

  42. Sakai T, Planinsic RM, Matier M, et al. Initial experience using continuous intravenous treprostinil to manage pulmonary artery hypertension in end-stage liver disease. Transpl Int 2009; 22: 554–61.

    Article  CAS  PubMed  Google Scholar 

  43. Cartin-Ceba R, Wiesner RH, Krowka MJ. Safety and efficacy of ambrisentan for the therapy of portopulmonary hypertension. Hepatology 2009; 50 (Suppl): A95 (abstract).

    Google Scholar 

  44. Krowka MJ, Fallon MB, Gish Mulligan, at al. MELD exception for portopulmonary hypertension. Liver Transpl 2006; 12 (Suppl): S114–6.

    Article  PubMed  Google Scholar 

  45. Grannas G, Neipp M, Hoeper M, et al. Indications for and outcomes after combined lung and liver transplantation: a single-center experience on 13 consecutive cases. Transplantation 2008; 85: 524–31.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN, USA

    Michael J. Krowka MD & Aynur Okcay MD

Authors
  1. Michael J. Krowka MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Aynur Okcay MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Liver Unit, Hospital Clinic, University of Barcelona, Villarroel 170, Barcelona, 08036, Spain

    Pere Ginès

  2. College of Medicine, Division of Gastroenterology and Hepatol, Mayo Clinic, 200 First St. S.W, Rochester, 55905, Minnesota, USA

    Patrick S. Kamath

  3. Liver Unit, Hospital Clinic, University of Barcelona, Barcelona, 08036, Spain

    Vicente Arroyo

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Krowka, M.J., Okcay, A. (2011). Pulmonary Alterations in Chronic Liver Failure. In: Ginès, P., Kamath, P., Arroyo, V. (eds) Chronic Liver Failure. Clinical Gastroenterology. Humana Press. https://doi.org/10.1007/978-1-60761-866-9_18

Download citation

  • DOI: https://doi.org/10.1007/978-1-60761-866-9_18

  • Published:

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-60761-865-2

  • Online ISBN: 978-1-60761-866-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation